PLA2R1 and thrombophilia: Yet there are still other biological mechanisms speculated to contribute to a more extensive hypercoagulable state in MN with anti-PLA2R antibodies (e.g. via intermediary pathways) [5], possibly not affecting conventional coagulation system tests to the same degree.